These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9556164)

  • 1. Pharmacokinetics of intra-arterially administered pirarubicin in plasma and cerebrospinal fluid of patients with glioma.
    Morikawa N; Mori T; Takeyama M; Hori S
    Biol Pharm Bull; 1998 Mar; 21(3):297-9. PubMed ID: 9556164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.
    Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 1999 Apr; 22(4):428-31. PubMed ID: 10328568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
    Morikawa N; Mori T; Abe T; Ghoda M; Takeyama M; Hori S
    Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related increases in cerebrospinal fluid concentrations of methotrexate in a postoperative patient with glioblastoma.
    Morikawa N; Mori T; Kamenofuchi Y; Kawashima H; Takeyama M; Hori S
    Ann Pharmacother; 1999 Sep; 33(9):952-6. PubMed ID: 10492499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate concentration in cerebrospinal fluid of the space created by tumor removal.
    Morikawa N; Mori T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 2000 Jun; 23(6):774-7. PubMed ID: 10864035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intra-arterial infusion of high dose methotrexate therapy in recurrent gliomas].
    Hayashi A; Kyuma Y
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1461-6. PubMed ID: 2117886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
    Yamada K; Takahama H; Nakai O; Takanashi T; Hosoya T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
    Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
    Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
    Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
    Marzolini C; Decosterd LA; Shen F; Gander M; Leyvraz S; Bauer J; Buclin T; Biollaz J; Lejeune F
    Cancer Chemother Pharmacol; 1998; 42(6):433-40. PubMed ID: 9788568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma.
    Xue H; Wang H; Kong L; Zhou H
    Chin Med J (Engl); 1998 Aug; 111(8):751-3. PubMed ID: 11245034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors.
    Morikawa N; Mori T; Kawashima H; Fujiki M; Abe T; Kaku T; Konisi Y; Takeyama M; Hori S
    Eur J Clin Pharmacol; 1998 Jul; 54(5):415-20. PubMed ID: 9754986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 2000 Jun; 23(6):784-7. PubMed ID: 10864038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma.
    Hill SA; Neuwelt EA
    J Neurosurg Nurs; 1982 Apr; 14(2):94-7. PubMed ID: 6811704
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue levels of pirarubicin (THP) in dogs following intra-arterial infusion].
    Sumiyoshi Y; Yokota K; Akiyama M; Kawaoto H; Kosugi I
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1621-6. PubMed ID: 1872619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
    Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C
    Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
    Chakraborty S; Filippi CG; Wong T; Ray A; Fralin S; Tsiouris AJ; Praminick B; Demopoulos A; McCrea HJ; Bodhinayake I; Ortiz R; Langer DJ; Boockvar JA
    J Neurooncol; 2016 Jul; 128(3):405-15. PubMed ID: 26945581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.